Pence wants $1.5M a year for life sciences institute

Back to TopCommentsE-mailPrintBookmark and Share

Gov. Mike Pence called last week for the state to spend $1.5 million a year to create a new life-sciences-focused research institute in Indianapolis.

The institute already has received full-throated support from John Lechleiter, CEO of Indianapolis-based Eli Lilly and Co. But privately, university leaders have questioned the idea as a potential competitor to the 5-year-old Clinical and Translational Sciences Institute, housed at the Indiana University School of Medicine in Indianapolis.

Pence’s appropriation request for what he calls the Indiana Applied Research Enterprise is modest because he wants the institute to seek out funding from private companies and industry groups, rather than what he describes as “the traditional model of federal grant-seeking, which our universities already employ.”

Indiana’s universities now derive about 10 percent of their research funding from industry sources, one of the highest percentages in the country.

Pence, however, wants to push the state’s research institutions to do more commercialization than they have been. His campaign website notes that Purdue University ranks No. 31 and IU ranked No. 111 among global universities for number of U.S. patents generated in 2011. The University of Notre Dame is Indiana’s other research university.

“While our universities are generating a lot of new innovation, a more intensive statewide approach can better help their efforts,” the Pence website states, adding, “Currently, our universities lag other Midwestern rivals in patents … there is room for improvement given their immense research capacity and talent.”

Pence thinks the institute could improve the situation because it would operate under liberal intellectual property policies that he thinks would free up researchers to pursue innovations.

Pence's website says the institute “will seek to create the ‘Wild West’ of university-based research.”

Lechleiter, in an Oct. 23 speech about the institute idea, said Lilly would donate an unspecified amount of money to sponsor research there. He also said the pharmaceutical company would allow its scientists to participate in collaborations at the institute.

And he said Lilly would hire a new employee to seek out alliances with Indiana’s universities and create an internal scorecard to measure how many in-state alliances it is forming each year.

“Within a year, I don’t want anybody within the state to say to Lilly, ‘You guys are hard to work with,’” Lechleiter said.


  • More Important Priority
    The State supported research efforts by Governor Pence should be commended. This would be good for CTSI to have a little competition. Is our State so naive to think that one research organization is enough to foster innovation. Oh I forgot, our State, for many years, has also been satisfied with just one medical school. Now, with the changes in health care that will be implemented soon, our State is not prepared with enough physicians and other healthcare provider to accommodate the increased number of Hoosiers entering the health care system. Purdue and Notre Dame would be the two logical schools to have their own medical schools. However, with the new president at Purdue, I am sure that that will not happen. One of Governor Pence's first health care initiative should be a new State medical school and not another tentacle of IU Health.

Post a comment to this story

We reserve the right to remove any post that we feel is obscene, profane, vulgar, racist, sexually explicit, abusive, or hateful.
You are legally responsible for what you post and your anonymity is not guaranteed.
Posts that insult, defame, threaten, harass or abuse other readers or people mentioned in IBJ editorial content are also subject to removal. Please respect the privacy of individuals and refrain from posting personal information.
No solicitations, spamming or advertisements are allowed. Readers may post links to other informational websites that are relevant to the topic at hand, but please do not link to objectionable material.
We may remove messages that are unrelated to the topic, encourage illegal activity, use all capital letters or are unreadable.

Messages that are flagged by readers as objectionable will be reviewed and may or may not be removed. Please do not flag a post simply because you disagree with it.

Sponsored by

facebook - twitter on Facebook & Twitter

Follow on TwitterFollow IBJ on Facebook:
Follow on TwitterFollow IBJ's Tweets on these topics:
Subscribe to IBJ